WUXING
DEAD

Serial Number

98056898

Owner

WUXI BIOLOGICS IRELAND LIMITED

Attorney

Michael T. Smith

Filing Date

Jun 23, 2023

Add to watchlist:

No watchlists yet
View on USPTO

WUXING Trademark

Serial Number: 98056898

WUXING is a trademark filed by WUXI BIOLOGICS IRELAND LIMITED on June 23, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

WUXI BIOLOGICS IRELAND LIMITED (49 trademarks)

MULLAGHARLIN,

Entity Type: 99

Trademark Details

Filing Date

June 23, 2023

Registration Date

Not Registered

Published for Opposition

May 28, 2024

Goods & Services

Computers; computer peripheral devices; computer operating programs, recorded; recorded computer software for optimizing and enhancing the management efficiency of laboratories; computer monitors; recorded and downloadable computer software for monitoring laboratory resources; computer software platforms for optimizing and enhancing the management efficiency of laboratories, recorded or downloadable; computer programs for software for optimizing and enhancing the management efficiency of laboratories, downloadable; computer software applications for software for optimizing and enhancing the management efficiency of laboratories, downloadable; interactive touchscreen terminals

Publicity consultation; compilation of information into computer databases; updating and maintenance of data in computer databases; Providing consumer product information via the Internet; compiling business data; product sales information; providing commercial information and advice for consumers in the choice of products and services; commercial administration of the licensing of the goods and services of others; business assistance, namely, outsourcing services; business consultancy services for digital transformation; Assist, consultancy and advisory services related to commercial business planning; outsourcing services, namely, procurement services for others being purchasing goods and services for other businesses

Technological research, namely, antibody drug research and development; conducting technical project studies, namely, studies for antibody drug research and development; research and development of new products for others; scientific laboratory services; Scientific research and development; biological research; Biomedical Research; Medical laboratory service; Pharmaceutical Research Services; computer programming; computer software design; updating of computer software; rental of computer laboratory software; maintenance of computer software; duplication of computer programs; Creating and maintaining web sites for others; installation of computer software; software as a service (SaaS) services featuring software for optimizing and enhancing the management efficiency of laboratories; electronic data storage; providing information relating to computer technology and programming via a website; Consulting services in the field of cloud computing; platform as a service (PaaS) featuring computer software platforms for optimizing and enhancing the management efficiency of laboratories; development of computer platforms; Structural and functional analysis of genomes; Research in the field of gene editing technology; Database development services; software engineering services for data processing; Provide temporary use of online non-downloadable single sign-on software; Rental of application software for optimizing and enhancing the management efficiency of laboratories; Design and development of computer programs

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 23, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 23, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 21, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jul 18, 2025 EX2G
SOU EXTENSION 2 FILED
Jul 18, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 18, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 20, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 20, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 20, 2025 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 22, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 22, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 22, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 23, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 28, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 28, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 8, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 23, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 26, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 4, 2024 GNFN
FINAL REFUSAL E-MAILED
Mar 4, 2024 GNFR
FINAL REFUSAL WRITTEN
Mar 4, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 16, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 13, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 13, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 13, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 3, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 26, 2023 NWOS
NEW APPLICATION ENTERED
Jun 27, 2023 NWAP